Morgan Stanley Reiterates Buy on Globe Life (GL) Shares

Globe Life Inc. (NYSE:GL) is one of the 13 High-Quality S&P 500 Financial Stocks According to Hedge Funds.

Globe Life Inc. (NYSE:GL) saw its Buy rating from Morgan Stanley reiterated by the firm’s analyst Bob Huang on February 23, 2026, with a price target of $176.

Prior to this, on February 9, 2026, Michael Clay Majors, the company’s Executive Vice President and Chief Strategy Officer, engaged in a significant insider transaction, selling 30,000 shares of Globe Life Inc. (NYSE:GL)’s stock in a transaction valued at approximately $4.41 million. With this move, Michael reduced his ownership stake in the company by 39%.

Earlier this month, on February 5, 2026, Globe Life Inc. (NYSE:GL) released its fourth-quarter and full-year 2025 earnings results, which highlighted a net income increase to $266 million, or $3.29 per share, up from $255 million, or $3.01 per share, in 2024. Alongside the increase, the company also noted an $8 million decrease in excess investment income due to lower average invested asset growth and lower average earned yield. Its 2026 earnings guidance includes a net operating income range of $14.95 to $15.65 per share.

Founded in 1900, Globe Life Inc. (NYSE:GL) is a provider of life and supplemental health insurance for middle-income families with headquarters in Texas.

While we acknowledge the potential of GL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Dividend Stocks With High Insider Buying and 10 Best Stocks to Buy in 2026 According to Reddit

Disclosure: None.  Follow Insider Monkey on Google News.